Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Stiff Total Knee Replacement After MUA
NCT02926248Phase 4Suspended
- Sponsor
- Hospital for Special Surgery
- Start
- May 2016
- Primary completion
- Mar 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Arthrofibrosis comparing Colchicine with Placebo (2 arms). Primary endpoint: Change in Range of Motion at 3 months. Started May 2016; status: suspended.
02
Drugs
colchicine
03
Conditions
Arthrofibrosis
Beyond the preview
Go deeper on NCT02926248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02926248.